Guizhou Xinbang Pharmaceutical Co., Ltd. (SHE:002390)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Pharmaceutical Distribution	4.75B	5.27B	5.28B	5.36B	4.86B
Pharmaceutical Distribution Growth	-10.03%	-0.10%	-1.53%	10.44%	-13.97%
Medical Services	1.64B	1.79B	1.86B	2.07B	1.97B
Medical Services Growth	-8.48%	-3.90%	-10.18%	5.24%	1.27%
Pharmaceutical Manufacturing	938.69M	843.52M	790.26M	704.12M	606.74M
Pharmaceutical Manufacturing Growth	11.28%	6.74%	12.23%	16.05%	-27.28%
Other Industries	2.09M	2.30M	8.61M	14.29M	18.15M
Other Industries Growth	-9.30%	-73.25%	-39.77%	-21.29%	-48.57%
Consolidated Offset	-1.29B	-1.45B	-1.59B	-1.68B	-1.60B
Total	6.03B	6.46B	6.35B	6.47B	5.85B
Total Growth	-6.63%	1.75%	-1.88%	10.71%	-12.16%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Northeast	15.64M	23.28M	24.46M	30.22M	22.40M
Northeast Growth	-32.83%	-4.83%	-19.05%	34.93%	-21.03%
North China	78.73M	94.84M	104.62M	112.57M	89.81M
North China Growth	-16.99%	-9.35%	-7.06%	25.34%	-20.54%
East China	730.94M	606.83M	529.11M	398.71M	289.72M
East China Growth	20.45%	14.69%	32.71%	37.62%	2.01%
South China	12.22M	11.84M	14.72M	12.43M	34.37M
South China Growth	3.20%	-19.59%	18.40%	-63.83%	-11.38%
Central China	39.44M	39.91M	39.66M	48.53M	42.44M
Central China Growth	-1.18%	0.61%	-18.27%	14.36%	-15.69%
Northwest	6.05M	7.06M	10.99M	12.13M	11.54M
Northwest Growth	-14.24%	-35.79%	-9.39%	5.13%	-11.20%
Southwest	6.44B	7.12B	7.22B	7.54B	6.92B
Southwest Growth	-9.61%	-1.27%	-4.27%	8.90%	-10.82%
Consolidated Offset	-1.29B	-1.45B	-1.59B	-1.68B	-1.60B
Overseas	-	-	-	-	36.63M
Overseas Growth	-	-	-	-	-78.16%
Total	6.03B	6.46B	6.35B	6.47B	5.85B
Total Growth	-6.63%	1.75%	-1.88%	10.71%	-12.16%

Source: S&P Global Market Intelligence.